Victory Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $220M | Sell |
9,152,541
-6,356,458
| -41% | -$166M | 0.12% | 189 |
|
|
2026
Q1 | $435M | Sell |
15,508,999
-4,287,366
| -22% | -$114M | 0.28% | 70 |
|
|
2025
Q4 | $493M | Buy |
19,796,365
+3,609,614
| +22% | +$91M | 0.28% | 74 |
|
|
2025
Q3 | $413M | Buy |
16,186,751
+1,071,384
| +7% | +$26.4M | 0.24% | 90 |
|
|
2025
Q2 | $372M | Buy |
15,115,367
+10,400,851
| +221% | +$243M | 0.24% | 91 |
|
|
2025
Q1 | $119M | Sell |
4,714,516
-438,345
| -9% | -$11.5M | 0.12% | 186 |
|
|
2024
Q4 | $137M | Buy |
5,152,861
+1,666,189
| +48% | +$45.2M | 0.13% | 164 |
|
|
2024
Q3 | $101M | Sell |
3,486,672
-856,415
| -20% | -$25M | 0.1% | 246 |
|
|
2024
Q2 | $122M | Buy |
4,343,087
+29,786
| +0.7% | +$820K | 0.12% | 181 |
|
|
2024
Q1 | $120M | Sell |
4,313,301
-758,552
| -15% | -$21M | 0.12% | 201 |
|
|
2023
Q4 | $146M | Buy |
5,071,853
+552,778
| +12% | +$16.7M | 0.15% | 145 |
|
|
2023
Q3 | $150M | Sell |
4,519,075
-3,613
| -0.1% | -$128K | 0.17% | 129 |
|
|
2023
Q2 | $166M | Sell |
4,522,688
-708,708
| -14% | -$27.6M | 0.18% | 122 |
|
|
2023
Q1 | $213M | Buy |
5,231,396
+745,948
| +17% | +$32.2M | 0.24% | 102 |
|
|
2022
Q4 | $230M | Sell |
4,485,448
-498,387
| -10% | -$23.9M | 0.26% | 91 |
|
|
2022
Q3 | $218M | Buy |
4,983,835
+286,166
| +6% | +$13.9M | 0.25% | 90 |
|
|
2022
Q2 | $246M | Buy |
4,697,669
+259,179
| +6% | +$13.2M | 0.28% | 76 |
|
|
2022
Q1 | $218M | Buy |
4,438,490
+655,810
| +17% | +$34M | 0.22% | 105 |
|
|
2021
Q4 | $223M | Sell |
3,782,680
-2,284
| -0.1% | -$113K | 0.21% | 114 |
|
|
2021
Q3 | $163M | Sell |
3,784,964
-367,350
| -9% | -$16.3M | 0.16% | 151 |
|
|
2021
Q2 | $163M | Sell |
4,152,314
-320,413
| -7% | -$12.5M | 0.16% | 153 |
|
|
2021
Q1 | $162M | Sell |
4,472,727
-328,975
| -7% | -$11.7M | 0.17% | 137 |
|
|
2020
Q4 | $177M | Sell |
4,801,702
-709,622
| -13% | -$26M | 0.2% | 111 |
|
|
2020
Q3 | $192M | Buy |
5,511,324
+259,450
| +5% | +$9.1M | 0.25% | 81 |
|
|
2020
Q2 | $163M | Sell |
5,251,874
-4,751,954
| -48% | -$161M | 0.22% | 100 |
|
|
2020
Q1 | $310M | Buy |
10,003,828
+5,046,825
| +102% | +$172M | 0.26% | 78 |
|
|
2019
Q4 | $184M | Sell |
4,957,003
-137,206
| -3% | -$4.89M | 0.22% | 101 |
|
|
2019
Q3 | $174M | Buy |
5,094,209
+3,856,992
| +312% | +$140M | 0.22% | 105 |
|
|
2019
Q2 | $50.9M | Buy |
1,237,217
+1,123,305
| +986% | +$44.6M | 0.1% | 301 |
|
|
2019
Q1 | $4.59M | Sell |
113,912
-749,060
| -87% | -$30M | 0.01% | 862 |
|
|
2018
Q4 | $35.7M | Buy |
862,972
+17,189
| +2% | +$714K | 0.09% | 362 |
|
|
2018
Q3 | $35.4M | Buy |
845,783
+38,389
| +5% | +$1.48M | 0.07% | 454 |
|
|
2018
Q2 | $27.8M | Buy |
807,394
+251,922
| +45% | +$8.61M | 0.06% | 511 |
|
|
2018
Q1 | $18.7M | Sell |
555,472
-19,015
| -3% | -$654K | 0.04% | 599 |
|
|
2017
Q4 | $19.7M | Buy |
574,487
+44,155
| +8% | +$1.51M | 0.04% | 584 |
|
|
2017
Q3 | $18M | Sell |
530,332
-367,097
| -41% | -$11.8M | 0.04% | 614 |
|
|
2017
Q2 | $28.6M | Sell |
897,429
-199,037
| -18% | -$6.28M | 0.07% | 475 |
|
|
2017
Q1 | $35.6M | Sell |
1,096,466
-369,690
| -25% | -$11.7M | 0.08% | 400 |
|
|
2016
Q4 | $45.2M | Sell |
1,466,156
-375,955
| -20% | -$11.5M | 0.11% | 327 |
|
|
2016
Q3 | $59.2M | Sell |
1,842,111
-254,858
| -12% | -$8.52M | 0.17% | 205 |
|
|
2016
Q2 | $70.1M | Buy |
2,096,969
+417,385
| +25% | +$13.3M | 0.28% | 111 |
|
|
2016
Q1 | $47.2M | Sell |
1,679,584
-460,211
| -22% | -$13.1M | 0.2% | 180 |
|
|
2015
Q4 | $65.5M | Sell |
2,139,795
-690,435
| -24% | -$21.7M | 0.27% | 108 |
|
|
2015
Q3 | $84.3M | Sell |
2,830,230
-595,914
| -17% | -$19.1M | 0.35% | 76 |
|
|
2015
Q2 | $109M | Sell |
3,426,144
-1,414,336
| -29% | -$46.1M | 0.4% | 53 |
|
|
2015
Q1 | $160M | Buy |
4,840,480
+1,183,103
| +32% | +$37.6M | 0.57% | 23 |
|
|
2014
Q4 | $108M | Sell |
3,657,377
-402,085
| -10% | -$11.5M | 0.4% | 66 |
|
|
2014
Q3 | $114M | Sell |
4,059,462
-643,104
| -14% | -$18M | 0.86% | 16 |
|
|
2014
Q2 | $132M | Buy |
4,702,566
+600,967
| +15% | +$17.1M | 0.9% | 16 |
|
|
2014
Q1 | $125M | Sell |
4,101,599
-56,380
| -1% | -$1.68M | 0.85% | 18 |
|
|
2013
Q4 | $121M | Sell |
4,157,979
-477,632
| -10% | -$13.9M | 0.85% | 16 |
|
|
2013
Q3 | $126M | Buy |
+4,635,611
| New | +$126M | 0.91% | 16 |
|
Other funds holding PFE
VCM
VPM
Victory Capital Management's PFE Position: Q2 2026 in Review
Victory Capital Management reduced its Pfizer (PFE) stake by 41% in Q2 2026, selling an estimated $166M and leaving 9,152,541 shares worth $220M. The position accounts for 0.12% of the portfolio, ranked #189.
Victory Capital Management first reported a position in PFE in Q3 2013 and has held it in 52 quarters since. The position peaked at $493M in Q4 2025. 2,429 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Victory Capital Management held 9,152,541 shares of Pfizer worth $220M as of Q2 2026.
- Victory Capital Management sold 6,356,458 Pfizer shares in Q2 2026, an estimated $166M.
- Pfizer made up 0.12% of Victory Capital Management's portfolio in Q2 2026, its #189 holding.
- Victory Capital Management first reported a position in Pfizer in Q3 2013 and has held it in 52 quarters since.
- Victory Capital Management's Pfizer position peaked at $493M in Q4 2025.
- 2,429 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.